AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

FULVESTRANT

19 registrations across 8 African markets— 16 active

Markets with FULVESTRANT

🇿🇦South Africa
9 registrations
9 active
🇬🇭Ghana
2 registrations
0 active
🇿🇼Zimbabwe
2 registrations
2 active
🇹🇿Tanzania
2 registrations
2 active
🇨🇮Côte d'Ivoire
1 registration
1 active
🇰🇪Kenya
1 registration
1 active
🇿🇲Zambia
1 registration
1 active
🇹🇳Tunisia
1 registration
0 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
FASLOCAN 250
SOLUTION; INJECTION
🇿🇼ZimbabweRHAEGAL PHARMACEUTICALSactiveMay 2031
FASLODEX
SOLUTION; INJECTION
🇿🇼ZimbabweASTRA ZENECA LIMITEDactiveApr 2030
Faslodex
Solution for Intramuscular Injection
🇿🇲ZambiaAstra Zeneca UK LimitedactiveFeb 2030
FULVESTRANT SANDOZ🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveJul 2029
FUVISTRA🇿🇦South AfricaRanbaxy Pharmaceutical (Pty) LtdactiveJun 2029
ACTIFULVE POWDER FOR SOLUTION FOR INJECTION AND ACTIFULVE DILUENT FOR SOLUTION FOR INJECTION🇿🇦South AfricaActivo Health (Pty) LtdactiveMay 2029
FULVAFIT
Solution For Injection
🇰🇪KenyaAUROBINDO PHARMA LIMITEDactiveApr 2029
DESOFAL🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveOct 2028
VESOTA🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveOct 2028
FULVEDEX 250 mg/5 ml🇿🇦South AfricaJuno Pharma SA (Pty) LtdactiveNov 2027
FULDEXA🇿🇦South AfricaAccord Healthcare (Pty) LtdactiveNov 2027
FASLODEX INJECTION🇬🇭Ghana—expiredAug 2026
FASLODEX INJECTION🇬🇭Ghana—expiredAug 2026
FASLODEX
Solution injectable / 250 mg
🇹🇳TunisiaASTRA ZENECA UK LtdexpiredAug 2013
FREXIVO🇿🇦South AfricaAstraZeneca Pharmaceuticals (Pty) LtdactiveJan 1900
FASLODEX🇿🇦South AfricaAstraZeneca Pharmaceuticals (Pty) LtdactiveJan 1900
FULVAFIT
Solution for Injection
🇹🇿TanzaniaAurobindo Pharma Limitedactive—
FASLODEX 250 MG SOLUTION INJECTABLE EN IM, BOITE DE 2 SERINGUES PREREMPLIES DE 5 ML🇨🇮Côte d'IvoireASTRAZENECA UK LIMITEDactive—
Faslodex 250mg
Solution for injection
🇹🇿TanzaniaAstraZeneca UK Limitedactive—

FULVESTRANT in Africa — Regulatory Overview

FULVESTRANT is registered across 8 African markets with 19 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Ghana, Zimbabwe, Tanzania and 4 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 19 registrations, 16 (84%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.